Vir Biotechnology and GSK announce global expansion to Phase 3 of COMET-ICE study evaluating VIR-7831 for the treatment of COVID-19

NEXT STORY
Generex Subsidiary NuGenerex Immuno-Oncology Announces World Class Scientific Advisory Board Appointments for its COVID-19 Vaccine Development Program
PREV STORY
Worldwide Industry for Enzyme-Linked Immunosorbent Assay Technologies to 2027 – by Test Type, Application and Geography
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Immunoassay Market to hit US $32.79 billion by 2028 – Global Insights on Trends, Value Chain Analysis, Regulatory Framework, Leading Players, Drivers, and Future Prospect: Adroit Market Research

author_avatar
NASDAQ Market News

APEIRON, the Medical University of Vienna and the Institute of Molecular Biotechnology Sign Licensing Agreement for a New Checkpoint Inhibitor

APEIRON strengthens its proprietary Cbl-b portfolio with cutting edge immunotherapy technology developed at IMBA ...

author_avatar
NASDAQ Market News

Rhythm Pharmaceuticals and Medison Pharma Partner to Commercialize IMCIVREE™ (setmelanotide) in Israel

author_avatar
NASDAQ Market News